Insight journal - Technology

Diagnostic imaging partnering : recent life science trends 2009-2014

Posted on 06 August 2014

Tags: , ,

Recent life science trends has seen tremendous developments in new diagnostic and medical imaging techniques. Imaging tools such as CT scans, endoscopes, PET, SPECT, ultrasound and MRI are all showing promise and precise accuracy in diagnosing diseases like cancer, hospital care, cardiovascular, etc.

According to the Current Agreements life science deals and alliance database, around 700 diagnostic imaging partnering deals were announced since 2009.

The Diagnostic Imaging Partnering Terms and Agreements report provides a detailed understanding and analysis of how and why companies enter diagnostic imaging partnering deals covering the following types of imaging technologies:

  • Imaging

o   CT

o   Molecular and nuclear

  • PET (Positron Emission Tomography)
  • SPECT( Single photon emission computed tomography)
  • MRI
  • Ultrasound
  • X-Ray
  • Angiography
  • Fluoroscopy
  • Mammography

The following figure shows overall diagnostic imaging partnering frequency between 2009 and July 2014. Generally, there is a consistent trend observed in diagnostic imaging partnering over the last 5 years with an average of 149 deals announced.

Figure 1: Diagnostic imaging partnering since 2009

1DI

 

 

 

 

 

 

Source: Current Agreements, 2014

With the onset of newer diseases so often, diagnostic tools reveal the onset and spread of the diseases and prove to be an indispensable tool for treatments. According to Current Agreements, big pharma and big biotech companies have a minor role to play in partnering for imaging technology

The figure below shows the most active players in the arena of diagnostic imaging dealmaking. GE healthcare tops the list with 38 partnership deals announced since 2009. GE Healthcare specializes in diagnostic technology and services and has a broad expertise in medical imaging and drug delivery technologies. The company mainly enters into collaborative R&D agreements for hospital care, cancer and cardiovascular therapy areas with other biopharma companies sharing their knowledge and expertise in this area.

Figure 2: Diagnostics partnering leading dealmakers since 2009

2DI

 

 

 

 

 

 

 

 

 

Source: Current Agreements, 2014

The following figure shows diagnostics deal making by imaging technology type. It is observed that the vast majority of deals are signed for ultrasound closely followed by interests in PET, MRI and endoscope techniques.

Figure 3: Diagnostic imaging partnering by technology type since 2009

3DI

 

 

 

 

 

 

 

 

 

 

Source: Current Agreements, 2014

Oncology is a popular area for diagnostic imaging dealmaking with over 262 deals signed since 2009. Other therapeutic focus areas in diagnostic partnering are hospital care and cardiovascular.

Figure 4: Diagnostic imaging partnering by therapeutic area since 2009

4DI

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Source: Current Agreements, 2014

As an emerging and exciting area for therapeutic intervention, diagnostic imaging deal making can have a high headline deal value. The following figure shows the leading diagnostic imaging deals by headline value of the deal when announced between 2009 and 2014.

Figure 5: Top diagnostic imaging deals by value since 2009

5DI

 

 

 

 

 

 

 

 

 

Source: Current Agreements, 2014

Imaging is gaining popularity with advancements in medical devices industry. Life sciences industries are banking hugely on the growth of diagnostic imaging market. With more and more companies merging to enhance development of imaging therapeutics (Eg: Recent acquisition of Aimago by Novadaq Technolgies), partnering trends are going to see rapid changes in the future.

The recently updated Diagnostic Imaging Partnering Terms and Agreements report published by Current Partnering provides full details of over 700 diagnostic imaging deals announced since 2009 and includes average deal terms including headline, upfront, milestone and royalty rates, where available. In addition, the report provides details of deals broken down by deal type, stage of development, company A-Z and technology type. More details here

Sources

The above information has been abstracted from the following resources:

Shamini Thiagarajan

Related

Read: more diagnostics deals in pharma, biotech, life science partnering deal news, insights and glossary

View: glossary definition for diagnostics

View: Other technology type reports

Read article: Companion Diagnostics: recent life science industry trends

View: CP Insight Partnering Scorecard – view top life science partnering deals by value

View: CP Insight Journal – the latest deal trend infographics for life science deal making

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Follow us on:LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

 

Print Friendly, PDF & Email

Leave a Reply